Skip to main content

Salura Patient Advocacy Partner. Glow

Salura Health provides patient-centric intelligence for life sciences organizations, transforming unstructured patient and provider conversations into decision-ready evidence. The company's PCINT™ Engine combines human qualitative expertise with AI-assisted classification and coding to explain the behaviors underlying outcomes data. Salura delivers interactive Impact Boards that organize insights around specific strategic questions, helping teams address issues like GLP-1 discontinuation and launch underperformance.

Washington, United States · HQ
Founded 20249700+ followers
Updated 9 days ago

Funding

Funding not disclosed

Funding rounds are not available yet.

Founders

Founder details are not available yet.

Product

Problem

Healthcare and life sciences organizations have access to outcomes data—claims, prescription fills, dashboards, and surveys—but these sources cannot explain the behavior underneath the numbers. Teams struggle to understand why patients abandon therapy, delay care, resist new medications, or disengage from support programs, leaving critical strategic questions unanswered.

Solution

Salura Health provides a Patient-Centric Intelligence™ platform that analyzes population-scale patient, provider, and caregiver conversations to uncover the beliefs, burdens, fears, workarounds, and social influences driving healthcare behaviors. The PCINT™ Engine combines human qualitative expertise with AI-assisted classification, coding, and synthesis, applying research-grade codebooks to verify stakeholder voices and translate findings into strategy-ready outputs. The company delivers interactive Impact Boards—research environments organized around a client's specific strategic question—along with full insights reports, executive summaries, and strategic implications tied to brand, launch, market access, patient support, medical affairs, or pipeline decisions. Salura's six-step methodology moves from defining the research question through source selection, voice verification, validated qualitative coding, research-model synthesis, and board-ready delivery.

Target Audience

Primary customers are commercial, medical affairs, patient engagement, and strategy teams at life sciences companies, digital health organizations, integrated care providers, specialty pharmaceutical brands, and patient advocacy organizations.

Features

  • Interactive Impact Boards that open with the most important strategic truth and organize analysis around specific client decisions
  • AI-assisted coding and classification combined with expert human synthesis to compress research timelines while preserving traceability
  • Rapid research sprints designed for active commercial, medical, and strategic decisions where traditional qualitative studies would miss planning windows
  • Patient journey mapping across diagnosis, initiation, persistence, discontinuation, and long-term management stages
  • HCP behavior analysis examining peer conversations and their effect on prescribing behavior before it appears in prescription data
  • PCINT™ Signals content hub with filters for case studies, blog posts, and reports, including gated research artifacts
This profile is AI-generated and may contain inaccuracies.